Standout Papers

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease... 2010 2026 2015 2020 530
  1. 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study (2010)
    Juha O. Rinne, David J. Brooks et al. The Lancet Neurology

Immediate Impact

1 by Nobel laureates 14 from Science/Nature 78 standout
Sub-graph 1 of 19

Citing Papers

Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
2023 Standout
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
2023 StandoutNature
43 intermediate papers

Works of Keith M. Gregg being referenced

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
2012
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
2010 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Keith M. Gregg 848 419 166 471 21 1.8k
Elias Schwam 557 619 271 888 37 2.6k
Robert A. Whittington 589 194 260 577 64 2.6k
John Messina 665 500 191 612 79 2.6k
Michael P. Murphy 967 133 56 142 51 2.1k
Konstanze Plaschke 443 102 93 387 74 1.9k
A. Persson 388 414 215 110 65 2.4k
Philip D. Kanof 479 220 394 120 37 2.3k
Hanne Gottrup 1679 465 354 269 59 2.8k
Lennart Paalzow 627 165 65 366 60 2.1k
Klaus Schiene 853 77 307 256 36 2.0k

All Works

Loading papers...

Rankless by CCL
2026